The dynamic role of business intelligence in developing effective planning strategies through analyzing data as an influential variable: Case of engineering the pharmaceutical sector in Jordan

Abstract

In the current pharmaceutical context of Jordan, the significance of Business Intelligence (BI) has emerged as a crucial factor in designing efficient planning methods. This research investigates the transformative impact of business intelligence (BI) in four key domains: drug development enhancement, operational optimization, compliance assurance, and market dynamics comprehension. The research highlights the need to utilize a data-driven methodology to emphasize the value of business intelligence (BI) tools in extracting valuable insights, facilitating strategic decision-making, and promoting operational efficiency. The results indicate that pharmaceutical organizations that utilize business intelligence (BI) can uncover concealed patterns, recognize chances for growth, and make well-informed decisions. Additionally, the capacity of business intelligence (BI) to integrate novel data has accelerated the development of resilient technical frameworks, thereby reinforcing its essential position within the pharmaceutical sector in Jordan. This research serves as evidence of the potential of business intelligence (BI) in facilitating innovation, surmounting obstacles, and eventually improving patient outcomes.